Gene: GUCA2B
Official Full Name: guanylate cyclase activator 2Bprovided by HGNC
Gene Summary: This gene encodes a preproprotein that is proteolytically processed to generate multiple protein products, including uroguanylin, a member of the guanylin family of peptides and an endogenous ligand of the guanylate cyclase-C receptor. Binding of this peptide to its cognate receptor stimulates an increase in cyclic GMP and may regulate salt and water homeostasis in the intestine and kidneys. [provided by RefSeq, Nov 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37447 | GUCA2B Knockout cell line (A549) | Human | GUCA2B | 1:3~1:4 | Negative | Online Inquiry |
GUCA2B Gene Knockout Cell Lines are specifically engineered cell lines in which the GUCA2B gene has been functionally disrupted or "knocked out." This innovative genetic modification allows researchers to analyze the biological effects of the GUCA2B gene and its role in various cellular processes. The GUCA2B gene, which encodes the guanylate cyclase protein involved in the signaling pathways for ion transport and cell regulation, is crucial for normal cellular function, particularly in the context of certain physiological and pathological conditions.
These cell lines serve as powerful tools in investigating the molecular mechanisms underlying conditions such as hypertension, heart failure, and certain gastrointestinal disorders. By studying the GUCA2B knockout models, researchers can identify how the absence of this gene affects signaling pathways, ion homeostasis, and overall cell health, paving the way for potential therapeutic targets or interventions. The unobstructed observation of these pathways enables a clearer understanding of disease mechanisms and may accelerate the discovery of novel biomarkers or treatment options.
One of the significant advantages of GUCA2B Gene Knockout Cell Lines compared to traditional cell culture methods is their well-characterized genetic background, which ensures reproducibility and reliability in experimental outcomes. Additionally, these knockout models can be employed alongside rescue experiments using complementary gene constructs to dissect gene function in specific cellular contexts.
For researchers and clinicians, these cell lines provide invaluable insight into gene function and its implications for human health, facilitating advancements in drug discovery and personalized medicine approaches. Furthermore, they can enhance experimental models of disease, allowing for more accurate predictions of human responses due to the specific modifications made.
Our company specializes in creating high-quality, biologically relevant cell lines, ensuring that they meet the rigorous standards required for advanced research applications. With a commitment to innovation and scientific excellence, we are dedicated to equipping researchers with the tools necessary to explore complex biological questions and develop impactful solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.